• Viromed Medical secured ÜTS registration in Turkey for its ViroCAP cold plasma device, clearing a key regulatory hurdle for local sales.
• Management cited existing orders of about 2,000 units, with shipments now set to proceed via local partners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Viromed Medical AG published the original content used to generate this news brief on August 28, 2026, and is solely responsible for the information contained therein.